MedTrace Logo

Study on Thrombosis Therapy in German Cancer Patients

NCT01559883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2014-08-15

No results posted yet for this study

Summary

The study aims to document the flow of German patients with cancer and acute deep vein thrombosis from first visit to diagnosis and treatment, the applied diagnostic procedures, and therapy modalities.

Conditions

Interventions

OTHER

no intervention is being made

This is a Non-Interventional Study (NIS)

Sponsors & Collaborators

  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • Axel Matzdorff, Prof.Dr. · Caritasklinikum Saarbrücken, St. Theresia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559883 on ClinicalTrials.gov